Matinas BioPharma(MTNB)
搜索文档
Matinas BioPharma(MTNB) - 2020 Q4 - Earnings Call Transcript
2021-03-30 01:13
Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q4 2020 Earnings Conference Call March 29, 2021 8:00 AM ET Company Participants Peter Vozzo - Investor Relations Jerome Jabbour - Chief Executive Officer Keith Kucinski - Chief Financial Officer James Ferguson - Chief Medical Officer Raphael Mannino - Chief Scientific Officer Hui Liu - Chief Technology Officer Theresa Matkovits - Chief Development Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Gregory Fraser - Truist Securities Operator Hello ...
Matinas BioPharma Holdings (MTNB) Investor Presentation - Slideshow
2021-03-16 03:39
| --- | --- | |------------------------|-------| | | | | | | | | | | | | | | | | Corporate Presentation | | | | | | | | | | | | March 2021 | | | (NYSE AMER: MTNB) | 1 | Forward-Looking Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are predictive in nature, that ...
Matinas BioPharma Holdings (MTNB) Investor Presentation - Slideshow
2020-12-03 03:35
| --- | --- | --- | |--------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation December 2020 | | | Forward-Looking Statement MTNB This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are predi ...
Matinas BioPharma(MTNB) - 2020 Q3 - Earnings Call Transcript
2020-11-07 10:10
Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q3 2020 Results Conference Call November 6, 2020 8:30 AM ET Company Participants Peter Vozzo - IR Jerry Jabbour - CEO Keith Kucinski - CFO Dr. James Ferguson - Chief Medical Officer Conference Call Participants Bert Hazlett - BTIG Yasmeen Rahimi - Piper Sandler Operator Greetings. Welcome to Matinas BioPharma Third Quarter 2020 Results Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal pre ...
Matinas BioPharma (MTNB) Investor Presentation - Slideshow
2020-09-18 05:53
| --- | --- | --- | |---------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation September 2020 | | | Forward-Looking Statement MTNB This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are pre ...
Matinas BioPharma(MTNB) - 2020 Q2 - Earnings Call Transcript
2020-08-11 10:14
Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q2 2020 Earnings Conference Call August 10, 2020 4:30 PM ET Company Participants Peter Vozzo - IR Jerry Jabbour - CEO Terri Matkovits - Chief Development Officer Conference Call Participants Michael Okunewitch - Maxim Group Gregg Gilbert - Truist Operator Welcome to the Matinas BioPharma Second Quarter 2020 Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a rem ...
Matinas BioPharma (MTNB) Investor Presentation - Slideshow
2020-06-04 04:05
| --- | --- | --- | |----------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation June 2020 | | | Forward-Looking Statement MTNB This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are predictive in ...
Matinas BioPharma(MTNB) - 2020 Q1 - Earnings Call Transcript
2020-05-12 10:45
Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Peter Vozzo - Investor Relations Jerry Jabbour - Chief Executive Officer Terry Ferguson - Chief Medical Officer Terri Matkovits - Chief Development Officer Conference Call Participants Bert Hazlett - BTIG Ed Tenthoff - Piper Sandler Jason McCarthy - Maxim Group Greg Fraser - SunTrust Chad Messer - Needham & Company Operator Welcome to the Matinas BioPharma First Quarter 2020 Results Con ...
Matinas BioPharma(MTNB) - 2019 Q4 - Earnings Call Transcript
2020-03-10 02:05
Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q4 2019 Results Earnings Conference Call March 9, 2020 8:00 AM ET Company Participants Peter Vozzo - Investor Relations Jerry Jabbour - Chief Executive Officer Terry Ferguson - Chief Medical Officer Terry Matkovits - Chief Development Officer Keith Kucinski - Chief Financial Officer. Conference Call Participants Robert Hazlett - BTIG Edward Tenthoff - Piper Sandler Greg Fraser - SunTrust Jason McCarthy - Maxim Group Operator Greetings, and welcome to the Matinas ...
Matinas BioPharma(MTNB) - 2019 Q3 - Earnings Call Transcript
2019-11-14 11:52
Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q3 2019 Earnings Conference Call November 13, 2019 8:00 AM ET Company Participants Peter Vozzo - Investor Relations Jerry Jabbour - Chief Executive Officer Keith Kucinski - Chief Financial Officer Terry Ferguson - Chief Medical Officer Conference Call Participants Jason McCarthy - Maxim Group Gregg Gilbert - SunTrust Robert Hazlett - BTIG Chad Messer - Needham & Company Jerry Isaacson - Roth Capital Operator Greetings, and welcome to the Matinas BioPharma Third ...